PharmEasy mails health minister for quick draft rules notification

API Holdings, the parent of PharmEasy, has sought the Union health minister’s intervention for quick notification of the draft e-pharmacy rules to remove regulatory uncertainty regarding their existence after the Drug Controller General of India (DCGI) issued show-cause notices to these platforms over online sale of drugs citing violation of norms.

In a letter written to the health minister Mansukha Mandaviya, API Holdings asked for an urgent meeting with the delegation of online pharmacies to iron out issues.

“We seek your support towards the quick notification of the draft e-pharmacy rules and the New Drugs, Medical Devices and Cosmetics Bill 2022 to remove any uncertainty and to harmonise all the existing regulations under which the e-pharmacy is already compliant,” the letter said.